Armata Pharmaceuticals, Inc. Common Stock (ARMP)
EBITDA Growth
771.28%
Quarterly · Period ending:
ARMP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported771.28%period ending
Latest reported771.28%period ending
ARMP Quarterly EBITDA YoY % (0.00% → 771.28%)
Year-over-year change
High-resolution chart · PNG
ARMP ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -25% | |
| 34.4828% | |
| -63.6364% | |
| -20.8333% | |
| -7.6923% | |
| -31.8182% | |
| 0% | |
| -14.2857% | |
| -2,700% | |
| 60% | |
| -2,300% | |
| -2,200% | |
| 0% |